Skip to main content

MetaVia Inc.

MTVA
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001638287

No open-market purchases or sales by MetaVia Inc. insiders were filed in the last 90 days; 17 institutions reported holding it in 13F filings for Q2 2026, worth $414.0K in total; no superinvestor holds it.

Q3 2022 vs. Q2 2022

How the institutions holding MetaVia Inc. changed between Q2 2022 and Q3 2022.

All holders in Q3 2022All holders in Q2 2022

13F holders of MTVA: Q2 2022 compared with Q3 2022
MeasureQ2 2022Q3 2022Change
Holders219−12
Shares1.22M16.1K−1.21M (−98.7%)
Value$582.0K$219.5K−$362.5K (−62.3%)

New holders (1)

Institutions that held MetaVia Inc. at the end of Q3 2022 but not at the end of Q2 2022.

Institutions new to MTVA in Q3 2022
InstitutionSharesValue% of portfolio
BNP Paribas Arbitrage, SA38$5200.00%

Sold out (13)

Institutions that held MetaVia Inc. at the end of Q2 2022 and filed for Q3 2022 without it.

Institutions that sold out of MTVA in Q3 2022
InstitutionShares, Q2 2022Value, Q2 2022
Murchinson Ltd.205,256$98.0K
Susquehanna International Group, LLP108,541$51.0K
Sabby Management, LLC93,376$45.0K
Geode Capital Management, LLC65,290$30.0K
Renaissance Technologies LLC59,356$28.0K
Mount Yale Investment Advisors, LLC57,425$28.0K
Two Sigma Securities, LLC40,496$19.0K
Millennium Management LLC24,056$11.0K
Northern Trust Corp17,155$8.00K
State Street Corp16,558$8.00K
Captrust Financial Advisors3,044$1.00K
Royal Bank of Canada166$0
Truvestments Capital LLC29$0